Clinical Trial Update: ELIAS: Early Loop-Recorder in Suspected Arrhythmogenic Syncope [Phase 4]

View source ↗

Summary

The ELIAS study evaluated the use of an early loop recorder in patients with suspected arrhythmogenic syncope and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Syncope

Drugs mentioned

• ELIAS (Early Loop-Recorder in Suspected Arrhythmogenic Syncope)

Snippet

Sponsor: Medtronic Cardiac Rhythm and Heart Failure | Conditions: Syncope | Phase 4 | Status: COMPLETED